Literature DB >> 27790853

Characterization of an epoxide-derived metabolite of dictamnine using high-performance liquid chromatography with hybrid linear trap quadrupole orbitrap mass spectrometry.

Pinning Feng1, Xinrong Hu2, Xiaoliang Wu3, Jun Dong4, Xiuyu Cai4.   

Abstract

Dictamnine (4-methoxyfuro[2,3-b]quinolone), a furoquinoline alkaloid of the Rutaceae plant family, has been reported to be a phototoxic and photomutagenic compound, whose exposure can cause carcinogenicity, cytotoxicity, and genotoxicity. Metabolic activation is suggested to play an important role in dictamnine-induced toxicities, and the epoxide metabolite of dictamnine has been reported to be the main intermediate in vitro. The objective of this study was to identify N-acetylcysteine conjugate(s) derived from this reactive dictamnine metabolite in vitro and in vivo. An N-acetylcysteine conjugate of dictamnine was detected in microsomal incubations of dictamnine, as well as bile and urine samples of rats treated with dictamnine. The data obtained from the present work will facilitate the understanding of the mechanism behind dictamnine-induced toxicities.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Dictamnine; Metabolic activation; N-acetylcysteine conjugates; Reactive metabolites; Toxicity

Mesh:

Substances:

Year:  2016        PMID: 27790853     DOI: 10.1002/jssc.201600980

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  2 in total

1.  Metabolic Profile of Skimmianine in Rats Determined by Ultra-Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Tandem Mass Spectrometry.

Authors:  Aihua Huang; Hui Xu; Ruoting Zhan; Weiwen Chen; Jiawei Liu; Yuguang Chi; Daidi Chen; Xiaoyu Ji; Chaoquan Luo
Journal:  Molecules       Date:  2017-03-23       Impact factor: 4.411

2.  The Modulatory Role of CYP3A4 in Dictamnine-Induced Hepatotoxicity.

Authors:  Zhuo-Qing Li; Li-Long Jiang; Dong-Sheng Zhao; Jing Zhou; Ling-Li Wang; Zi-Tian Wu; Xian Zheng; Zi-Qi Shi; Ping Li; Hui-Jun Li
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.